Patents/Assignees

Medgene Therapeutics, Inc.

1 patent in portfolio

US12617864utility2026
Methods of Activating and Proliferating Exhausted CD8 T Cells, CD8 T Cells with Enhanced Activity Prepared by the Same, and Uses Thereof
0 cites